By EDWARD OMETE
In Summary
"In 15 years, the health industry will be what the
German automobile industry has been in the past." These opening remarks
from a presentation by a vice president of one of the biggest global
medical products manufacturer and distributor reaffirms what we have
consistently been saying: health care is happening.
But the remarks are followed by a caveat: “The investors
must know which sectors the growth will come from and where the maximum
returns will be.”
Figures for the German health industry suggest that
even for a highly industrialised nation like theirs, manufacturing and
similar sectors are slowly ceding ground and will have been surpassed by
healthcare in terms of direct and indirect contribution to the economy
soon if it hasn’t happened.
For a long time, the West has been the top revenue
earner for such firms. However “emerging markets” as Africa, Latin
America and similar regions are called, is where future growth in
revenue will come from.
Of course the GDP and per capita expenditure in
Kenya will not rise fast enough to match the figures in developed world.
But affordability is not permanent because economic situations change.
The recognition that the health segment’s growth
will plateau in the next two decades or so in terms of revenue in the
West is a dawning reality for many firms.
If it is in terms of equipment almost all hospitals
are saturated with equipment, uninsured patients in such markets are
low vis-a-vis emerging markets as is the use of “high end” medicines.
Consumption of medicine is driven by large
population and illness, both are high in emerging markets. Due to
declining populations, many nations in the West are faced with issues
like aging group whose health needs are almost catered for and at high
cost.
The steady rise in cost of healthcare is making
margins lower by the day for managers of these systems. Previously
unregulated areas are now facing the introduction of cost reduction
strategies to rein in these costs.
Financial muscle
The outcome is that it is becoming less profitable
and by extension less inviting for players in these systems. In the case
of Germany with a population growth rate almost half of Kenya’s and a
much higher life expectancy, high operational costs, wages an
infrastructural costs are a reality. In the long run, therefore, these
traditional revenue generation strongholds are also going to be
affected.
For big companies, strategies to stay alive include
looking outside and expanding to pave the way for entry elsewhere.
Reconsolidation is the first step that is happening via acquisition of
strategic future collaborators, spinning off new entities all aligned
within their “next” play.
One of the common ways is acquisitions around core
operations; equipment makers will soon also start financing and
distribution. As a local health entrepreneur, the question is where your
organisation will be aligned in this new era. For some exit
preparations are necessary for a bevy of suitors that must start
trooping in soon.
The reality is that without financial muscle we
cannot compete with the new entrants, thus mergers between local
entities should start.
Email: info@healthinfo.co.ke; Twitter: @healthinfoK
No comments :
Post a Comment